Liquidia Q1 net loss $38.4M ($0.45/sh); PDUFA May 24; court dismisses UTHR cross-claim

Liquidia Corp

2025-Q1 EPS reported -$0.45 revenue$3,120,000

Net loss of $38.4M ($0.45 per share) vs $30.1M ($0.40) prior year; cash $169.8M.
Revenue $3.1M from Sandoz promotion agreement; R&D down 31% as shift to commercialization.
PDUFA goal date May 24, 2025 for YUTREPIA NDA; FDA accepted Class 1 resubmission.
District Court dismissed UTHR cross-claim challenging PH-ILD amendment; UTHR may appeal.
Amended HCR agreement provides up to $100M additional financing for commercial launch.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.